Topical & Transdermal Analytical Services

At MedPharm, our Analytical Services are not just a checkpoint—they are a strategic cornerstone of successful pharmaceutical development. We specialize in topical and transdermal drug products, providing analytical and bioanalytical testing to support every phase of the product lifecycle, from early-stage formulation to clinical development and commercial release.

Whether you require custom method development, stability support, or bioanalytical insights, MedPharm delivers high-quality, regulatory-compliant data to inform your decisions and accelerate your progress.

What We Offer

Analytical methods are developed in consultation with the client and are specific to the stage of work. This can range from a simple assay-only method for very early R&D work to a fully validated, phase-appropriate related substances method for clinical trial or commercial batches.

Our group provides services designed to meet the needs of our clients during various stages of drug development, including:

Method Development/Implementation

Method Validation

Study Sample Analysis

Forced Degradation

Scientist performing analytical testing using microscopy for topical and transdermal drug products

Analytical Strategy

Phase-Appropriate Method Design: Methods aligned to development stage—from early feasibility to stability-indicating approaches for clinical and commercial programs.
End-to-End Method Support: Development through validation to ensure reliable, reproducible, and compliant methods (ICH, USP, FDA, EMA).
Characterization & Stability Insights: Impurity profiling and forced degradation to understand degradation pathways to support specifications and shelf-life.

Regulatory Guidance

The MedPharm analytical team operates under ICH Q2 (R2) guidance for the validation of analytical procedures.
This guidance provides the framework for all analytical work, including R&D development.
It ensures each stage of work flows smoothly into the next, avoiding unnecessary repetition and supporting the development of phase-appropriate methods.

Our Instrumentation

Our group uses HPLC, UHPLC, and GC to analyze a wide range of analytes and provide accurate, high-quality data which is then used to characterize formulations from R&D through to commercial release.

HPLC / UHPLC	GC
Shimadzu i-Series	Shimadzu GC2010
Shimadzu Nexera	Agilent 8890
Agilent 1200 / 1260 / 1290	Agilent 7690B
Waters Alliance 2695 and ARC	Agilent 7697A Headspace
Detectors: DAD, ELSD, PDA, RI, UV, VWD, FLD	Detectors: TCD and FID

Ask A Scientist

Science moves fast. So do we. Ask our experts now.

sciencechat@medpharm.com

Get A Quote

Big ideas deserve fast action. Let’s kick off your quote today.

busdev@medpharm.com

Analytical Services